Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs8078651 | chr17:47409222 | T/C | 4.2E-6 | 175 | 25.77 | 23.03 | 15 | KM Plot |
PCPG | rs8079884 | chr17:80517675 | T/C | 4.21E-5 | 178 | 25.97 | 19.72 | 7.2 | KM Plot |
PCPG | rs8083001 | chr18:72165058 | A/G | 0.000318 | 178 | 24.62 | 30.63 | 6.17 | KM Plot |
PCPG | rs8097180 | chr18:44147853 | C/T | 1.86E-5 | 178 | 25.4 | 25.53 | 11.78 | KM Plot |
PCPG | rs8099944 | chr19:19716054 | G/A | 0.000439 | 174 | 24.93 | 27.75 | 20.25 | KM Plot |
PCPG | rs8104594 | chr19:48087974 | T/C | 0.000124 | 170 | 25.35 | 24.53 | 25.87 | KM Plot |
PCPG | rs8109130 | chr19:19668738 | A/G | 0.000465 | 178 | 25.67 | 27.2 | 20.25 | KM Plot |
PCPG | rs8110266 | chr19:19723883 | C/T | 0.000377 | 173 | 25.17 | 26.88 | 20.25 | KM Plot |
PCPG | rs8113107 | chr19:19669507 | G/T | 0.000314 | 178 | 25.77 | 26.05 | 23.48 | KM Plot |
PCPG | rs8127206 | chr21:38442208 | T/C | 4.52E-6 | 178 | 25 | 26.57 | 3.7 | KM Plot |
PCPG | rs8132580 | chr21:38452027 | T/A | 9.52E-9 | 176 | 25.17 | 25.4 | 3.83 | KM Plot |
PCPG | rs8140283 | chr22:21290360 | A/G | 7.74E-5 | 177 | 12.57 | 31.68 | 25.2 | KM Plot |
PCPG | rs8180054 | chr3:80553618 | C/G | 0.000164 | 178 | 26.43 | 24.53 | 19.87 | KM Plot |
PCPG | rs8180743 | chr7:90850220 | A/T | 2.81E-6 | 177 | 25.17 | 25.87 | 24.7 | KM Plot |
PCPG | rs823692 | chr6:7490617 | A/C | 0.000193 | 178 | 15.82 | 42.87 | 24.85 | KM Plot |